Harald zur Hausen, MD

Affiliations:

Website:

http://www.nobelprize.org/nobel_prizes/medicine/laureates/2008/hausen-bio.html

Google:

Bio:

http://www.dkfz.de/en/zurhausen/
The Nobel Prize in Physiology or Medicine 2008 was divided, one half awarded to Harald zur Hausen for his discovery of human papilloma viruses causing cervical cancer, the other half jointly to Françoise Barré-Sinoussi and Luc Montagnier for their discovery of human immunodeficiency virus.
http://www.e-fellows.net/Studium/Infos-speziell-fuer/Mediziner/Wissen-fuer-Mediziner/Interview-mit-Nobelpreistraeger-Prof.-Harald-zur-Hausen
(Show more)

Cross-listing: Cell & Gene Therapy Tree - Microtree

Tree Publications Similar researchers PubMed Report error

Parents

Werner Henle	post-doc	1966-1969	Penn
Eberhard Wecker	research scientist	1969	Universität Würzburg
(Habilitation)

Children

Jürgen A. Kleinschmidt	grad student		Deutsches Krebsforschungszentrum (Cell & Gene Therapy Tree)
Bjoern Schwer	grad student		(Neurotree)

Collaborators

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Borkosky SS, Whitley C, Kopp-Schneider A, et al. (2012) Epstein-Barr virus stimulates torque teno virus replication: a possible relationship to multiple sclerosis. Plos One. 7: e32160
zur Hausen H. (2009) Childhood leukemias and other hematopoietic malignancies: interdependence between an infectious event and chromosomal modifications. International Journal of Cancer. Journal International Du Cancer. 125: 1764-70
zur Hausen H, de Villiers EM. (2009) TT viruses: oncogenic or tumor-suppressive properties? Current Topics in Microbiology and Immunology. 331: 109-16
zur Hausen H. (2008) Novel human polyomaviruses--re-emergence of a well known virus family as possible human carcinogens. International Journal of Cancer. Journal International Du Cancer. 123: 247-50
zur Hausen H. (1999) Immortalization of human cells and their malignant conversion by high risk human papillomavirus genotypes. Seminars in Cancer Biology. 9: 405-11
Rothmann T, Hengstermann A, Whitaker NJ, et al. (1998) Replication of ONYX-015, a potential anticancer adenovirus, is independent of p53 status in tumor cells. Journal of Virology. 72: 9470-8
Hermanns J, Schulze A, Jansen-Db1urr P, et al. (1997) Infection of primary cells by adeno-associated virus type 2 results in a modulation of cell cycle-regulating proteins. Journal of Virology. 71: 6020-7
zur Hausen H. (1996) Papillomavirus infections--a major cause of human cancers. Biochimica Et Biophysica Acta. 1288: F55-78
Dürst M, Seagon S, Wanschura S, et al. (1995) Malignant progression of an HPV16-immortalized human keratinocyte cell line (HPKIA) in vitro. Cancer Genetics and Cytogenetics. 85: 105-12
Wolf J, Pawlita M, Klevenz B, et al. (1993) Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells. International Journal of Cancer. Journal International Du Cancer. 53: 621-7